ACC: Bempedoic Acid Cuts Cardiovascular Event Risk in Statin-Intolerant
MONDAY, March 6, 2023 -- Treatment with bempedoic acid is associated with a lower risk for major adverse cardiovascular events among statin-intolerant patients, according to a study published online March 4 in the New England Journal of Medicine to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Cardiovascular | Cholesterol | Heart | Pharmaceuticals | Statin Therapy | Study